Alphabiome is a startup based in the United States, most recent round Seed.
Alphabiome is a company headquartered in the United States. Its most recent tracked round is Seed.
Alphabiome develops AI technology that reads raw, unannotated genetic sequencing data across multiple organisms to predict patient responses to therapies, enabling faster and more precise drug development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.